Catalyst Wire Dossier Catalyst Wire Dossier

Ultiva

remifentanil · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for Ultiva, covering 2008-10-16 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: ULTIVA — Supplemental Application (Mylan Institutional LLC)

See pricing